B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gefarnate

74 PubMed studies analyzed · 12 RCTs · Evidence Score: 48.7

Research Domains

Gefarnate has been studied across 14 research domains including 🦠 Gut & Microbiome, 🔬 Inflammation, ❤️ Cardiovascular, 🧘 Stress & Anxiety, 🌤️ Mood & Depression. The primary research focus is 🦠 Gut & Microbiome with 14% of studies addressing this area.

Loading evidence profile...

This evidence profile for Gefarnate is generated deterministically from 74 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.